BUY Alivus Life Sciences Limited — Hem Securities
byHem SecuritiesHorizon: NA (inferred 1 year)16 Jul 2024via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active long-term BUY call on this stock
Advisor consensus · same horizon·29 Apr · 4mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Alivus Life Sciences
- BUY — Siddharth Rai Mangala9 Sept 2026 · ~2 weeks · target ₹1,530 · SL hit
- BUY — Shrikant Chouhan, Kotak Securities30 Jun 2026 · ~3 months · target ₹1,315 · Target hit
- BUY — ICICI Securities15 May 2026 · ~1 year · target ₹1,235 · Target hit
- BUY — ICICI Securities23 Jan 2026 · ~1 year · target ₹1,190 · Target hit
- BUY — ICICI Securities7 Nov 2025 · ~1 year · target ₹1,180 · Target hit
More from Hem Securities
- BUY The South Indian Bank30 Jun 2026 · ~3 months · target ₹50 · Target hit
- BUY Allied Blenders and Distillers11 Jun 2026 · ~3 months · target ₹655 · Target hit
- BUY CSB Bank14 Nov 2024 · ~1 year · target ₹350 · Target hit
- BUY S.J.S. Enterprises6 Nov 2024 · ~1 year · target ₹1,458 · Target hit
- BUY Power Grid Corporation of India5 Nov 2024 · ~1 year · target ₹365 · Expired

